Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CFO Robert Thomas Freeman sold 6,744 shares of the stock in a transaction that occurred on Thursday, March 27th. The shares were sold at an average price of $17.89, for a total transaction of $120,650.16. Following the completion of the transaction, the chief financial officer now owns 1,464,419 shares in the company, valued at $26,198,455.91. This represents a 0.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Robert Thomas Freeman also recently made the following trade(s):
- On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.89, for a total value of $233,335.35.
- On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $226,697.56.
- On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
- On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total transaction of $3,895,000.00.
Alignment Healthcare Stock Performance
ALHC traded up $0.07 during trading hours on Tuesday, reaching $18.69. The company's stock had a trading volume of 1,833,629 shares, compared to its average volume of 1,501,379. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. The company's 50-day moving average is $15.36 and its 200-day moving average is $13.06. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $18.92. The firm has a market cap of $3.58 billion, a PE ratio of -24.32 and a beta of 1.49.
Analysts Set New Price Targets
A number of equities analysts recently weighed in on ALHC shares. Barclays upped their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research note on Friday, February 28th. Piper Sandler increased their price objective on Alignment Healthcare from $14.00 to $21.00 and gave the stock an "overweight" rating in a report on Tuesday, March 4th. William Blair restated an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stephens reaffirmed an "overweight" rating and set a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. Finally, Bank of America lifted their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a "buy" rating in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Alignment Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $14.83.
View Our Latest Analysis on Alignment Healthcare
Hedge Funds Weigh In On Alignment Healthcare
Institutional investors and hedge funds have recently modified their holdings of the business. R Squared Ltd bought a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $55,000. RiverPark Advisors LLC acquired a new position in Alignment Healthcare in the 4th quarter valued at $106,000. Tower Research Capital LLC TRC lifted its position in shares of Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after acquiring an additional 6,286 shares during the period. Ballentine Partners LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth $121,000. Finally, Aigen Investment Management LP bought a new position in shares of Alignment Healthcare in the fourth quarter worth $129,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.
Alignment Healthcare Company Profile
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
